There are now a number of other drugs in the same class in different stages of development, which have been shown to be even more potent inhibitors of hepatitis B replication. The large experience ...

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of the virus in the body, such as HBV antigens or antibodies. They also ...

Hepatitis B virus (HBV) infection is associated with liver diseases, including chronic hepatitis, which notably increases the risk of cirrhosis and hepatocellular carcinoma (HCC) development. Although ...

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer than six months are considered "chronic." Chronic hepatitis B (CHB ...

Hepatitis B is a lifelong infection of the liver caused ... traditional therapeutics for most patients - can inhibit viral replication and bring hepatitis under control, but they cannot eradicate ...